Sibelius signs development contract with the global integrated medicine company, CellResearch Corp Pte. Limited (CRC). Founded in 2002, CellResearch Corp provides high quality primary cell strains, culture media and research service support to researchers and corporations the world over. CRC has specialist knowledge and experience in the field of stem/progenitor cells from the amniotic lining of the umbilical cord membrane and its applications.

Share this post: